Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1395605 | European Journal of Medicinal Chemistry | 2014 | 13 Pages |
•Novel tricyclic pyrazoles were synthesized.•A multicomponent methodology was developed for the synthesis of novel compounds.•Inhibition of PDE10A activity and SAR study was performed.
Novel pyrazolo[5,1-f][1,6]naphthyridines, pyrazolo[5,1-a][2,6]naphthyridines, pyrazolo[5,1-a][2,7]naphthyridines and pyrazolo[5,1-a]isoquinolines phenylimidazole/benzimidazole ethylene-linked were designed and synthesized for PDE10A interaction. An AgOTf and proline-cocatalyzed multicomponent methodology based on use of o-alkynylaldehydes, tosylhydrazide and ketones was developed and proved to be a convenient route for assembly of most of the novel tricyclic pyrazoles synthesized. Pyrazolo[5,1-f][1,6]naphthyridine 43 and 59, pyrazolo[5,1-a][2,6]naphthyridine 66, and pyrazolo[5,1-a][2,7]naphthyridine 42 showed the highest affinity for PDE10A enzyme (IC50 = 40, 42, 40, 55 nM, respectively).
Graphical abstractSynthesis, inhibition of PDE10A activity of novel tricyclic pyrazoles are described.Figure optionsDownload full-size imageDownload as PowerPoint slide